Time-dependent effects of rifampicin on staphylococcal biofilms

International Journal of Artificial Organs

Volumn 33, Issue 9, 2010, Pages 621-626

  Gattringer, Klaus Bernhard ^a   Suchomel, Miranda ^a   Eder, Michaela ^a   Lassnigg, Andrea M ^a   Graninger, Wolfgang ^a   Presterl, Elisabeth ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Biofilms; Rifampicin; Staphylococcus epidermidis

Indexed keywords

BACTERIOLOGY; MICROWAVE INTEGRATED CIRCUITS;

% REDUCTIONS; 1 MINUTES; COLUMBIA; CRYSTAL VIOLET; IMPLANT INFECTIONS; MICROTITER PLATES; OPTICAL DENSITY RATIO; RIFAMPICIN; STAPHYLOCOCCUS EPIDERMIDIS; TIME-DEPENDENT EFFECTS;

BIOFILMS;

RIFAMPICIN;

ARTICLE; BACTERIAL GROWTH; BACTERICIDAL ACTIVITY; BACTERIUM CULTURE; BACTERIUM ISOLATE; BIOFILM; CONTROLLED STUDY; DRUG EFFECT; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OPTICAL DENSITY; QUANTITATIVE ANALYSIS; STAPHYLOCOCCUS EPIDERMIDIS; THICKNESS; TIME;

EID: 78049469209     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139881003300907     Document Type: Article

References (24)

1. Baddour LM, Wilson WR. Infections of Prosthetic Valves and Other Cardiovascular Devices. In: Mandell G, Benett J, Dolin R, eds. Practice and principles of infectious diseases. 6 ed. Philadelphia: Elsevier; 2005: 1022-44.
2. Beckmann SE, Henderson DE. Infections Caused by Percutaneous Intravascular Devices. In: Mandell G, Benett J, Dolin R, editors. Principles and practice of infectious diseases. 6 ed. Philadelphia: Elsevier; 2005; 3347-62.
3. Del Pozo JL, Patel R. Clinical practice. Infection associated with prosthetic joints. N Engl J Med 2009; 361: 787-94.
4. Peters G. Pathogenesis of S epidermidis foreign body infections. Br J Clin Pract (Suppl) 1988; 57: S62-5.
5. Elhanan G, Raz R, Pitlik SD, et al. Bacteraemia in a community and a university hospital. J Antimicrob Chemother 1995; 36: 681-95.
6. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science 1999; 284: 1318-22.
7. Uckay I, Pittet D, Vaudaux P, Sax H, Lew D, Waldvogel F. Foreign body infections due to Staphylococcus epidermidis. Ann Med 2009; 41: 109-19.
8. Zimmerli W, Widmer AF, Blatter M, Frei R, Ochsner PE. Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group. JAMA 1998; 279: 1537-41.
9. Casey AL, Mermel LA, Nightingale P, Elliott TS. Antimicrobial central venous catheters in adults: a systematic review and meta-analysis. Lancet Infect Dis 2008; 8: 763-76.
10. Sacar M, Goksin I, Baltalarli A, et al. The prophylactic efficacy of rifampicin-soaked graft in combination with systemic vancomycin in the prevention of prosthetic vascular graft infection: an experimental study. J Surg Res 2005; 129: 329-34.
11. Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, Yolken RH, eds. Manual of Clinical Microbiology. 8 ed. Washington DC: ASM Press; 2003.
12. Presterl E, Lassnigg A, Parschalk B, Yassin F, Adametz H, Graninger W. Clinical behavior of implant infections due to Staphylococcus epidermidis. Int J Artif Organs 2005; 28: 1110-8.
13. Christensen GD, Simpson WA, Younger JJ, et al. Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices. J Clin Microbiol 1985; 22: 996-1006.
14. Hellmark B, Unemo M, Nilsdotter-Augustinsson A, Soderquist B. Antibiotic susceptibility among Staphylococcus epidermidis isolated from prosthetic joint infections with special focus on rifampicin and variability of the rpoB gene. Clin Microbiol Infect 2009; 15: 238-44.
15. Darouiche RO. Treatment of infections associated with surgical implants. N Engl J Med 2004; 350: 1422-9.
16. Zimmerli W, Widmer AF, Blatter M, Frei R, Ochsner PE. Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group. JAMA 1998; 279: 1537-41.
17. Saginur R, Stdenis M, Ferris W, et al. Multiple combination bactericidal testing of staphylococcal biofilms from implant-associated infections. Antimicrob Agents Chemother 2006; 50: 55-61. (Pubitemid 43042902)
18. Zheng Z, Stewart PS. Penetration of rifampin through Staphylococcus epidermidis biofilms. Antimicrob Agents Chemother 2002; 46: 900-3.
19. Liang X, Wang A, Cao T, et al. Effect of cast molded rifampicin/silicone on Staphylococcus epidermidis biofilm formation. J Biomed Mater Res A 2006; 76: 580-8.
20. Fleer A, Verhoef J, Pascual HA. Coagulase-negative staphylococci as nosocomial pathogens in neonates. The role of host defense, artificial devices, and bacterial hydrophobicity. Am J Med 1986; 80: 161-5.
21. Russell AD. Biocide use and antibiotic resistance: the relevance of laboratory findings to clinical and environmental situations. Lancet Infect Dis 2003; 3: 794-803.
22. Presterl E, Suchomel M, Eder M, et al. Effects of alcohols, povidone-iodine and hydrogen peroxide on biofilms of Staphylococcus epidermidis. J Antimicrob Chemother 2007; 60: 417-20.
23. Gilbert P, Das JR, Jones MV, Allison DG. Assessment of resistance towards biocides following the attachment of micro-organisms to, and growth on, surfaces. J Appl Microbiol 2001; 91: 248-54.
24. Ge Z, Wang Z, Wei M. Measurement of the concentration of three antituberculosis drugs in the focus of spinal tuberculosis. Eur Spine J 2008; 17: 1482-7.